» Articles » PMID: 34013709

Is Bioavailable Vitamin D Better Than Total Vitamin D to Evaluate Vitamin D Status in Obese Children?

Overview
Date 2021 May 20
PMID 34013709
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Free hormones are biologically more active in target tissues. Thus, measurement of vitamin D taking into account bioavailability and free vitamin D may be preferable, especially when evidence is contradictory, as in obese children. In order to assess bioavailablity and free vitamin D, using a previously reported formula, vitamin D-binding protein (VDBP) level was measured and VDBP polymorphisms were also evaluated because of variations in binding affinity.

Methods: Eighty-four obese and 78 healthy children were included. Anthropometry, calcium, phosphorus, alkaline-phosphatase, parathyroid hormone (PTH), 25 hydroxyvitamin D [25(OH)D], bioavailable-free vitamin D, and VDBP concentration and polymorphism were evaluated in the whole group.

Results: Obese girls had significantly higher PTH than normal weight girls (p=0.001). Regardless of gender, obese children had significantly higher concentrations of VDBP (p=0.008) and PTH (p=0.002). When samples taken in winter were analyzed, PTH and VDBP were found to be higher and bioavailable and free vitamin D lower in the obese group. There was no difference in terms of total vitamin D between groups during the winter season.

Conclusion: While total, free, and bioavailable vitamin D in the obese group was similar to the control group in autumn, free and bioavailable vitamin D in the winter was lower in the obese than the control group. In addition, PTH was higher in the obese group in both autumn and winter. Therefore, more research is needed to evaluate the variability of free and bioavailable vitamin D according to body habitus, season and the effect any differences may have.

Citing Articles

Association of vitamin D levels with anthropometric and adiposity indicators across all age groups: a systematic review of epidemiologic studies.

Abiri B, Valizadeh M, Ahmadi A, Amini S, Nikoohemmat M, Abbaspour F Endocr Connect. 2023; 13(2).

PMID: 38032745 PMC: 10831555. DOI: 10.1530/EC-23-0394.

References
1.
Hoofnagle A, Eckfeldt J, Lutsey P . Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. N Engl J Med. 2015; 373(15):1480-2. PMC: 4654614. DOI: 10.1056/NEJMc1502602. View

2.
Chun R, Shieh A, Gottlieb C, Yacoubian V, Wang J, Hewison M . Vitamin D Binding Protein and the Biological Activity of Vitamin D. Front Endocrinol (Lausanne). 2019; 10:718. PMC: 6821678. DOI: 10.3389/fendo.2019.00718. View

3.
Powe C, Evans M, Wenger J, Zonderman A, Berg A, Nalls M . Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369(21):1991-2000. PMC: 4030388. DOI: 10.1056/NEJMoa1306357. View

4.
Bikle D, Siiteri P, Ryzen E, Haddad J . Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab. 1985; 61(5):969-75. DOI: 10.1210/jcem-61-5-969. View

5.
Naderpoor N, Shorakae S, Abell S, Mousa A, Joham A, Moran L . Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance. J Steroid Biochem Mol Biol. 2017; 177:209-215. DOI: 10.1016/j.jsbmb.2017.07.012. View